�鶹ֱ�� Advises EpiVax in Acquisition by SV Health Investors

�鶹ֱ�� & Lardner LLP served as legal advisor to EpiVax Inc., a leading bioanalytical contract research organization specializing in immunogenicity risk assessments for pharmaceutical and biotech companies, in its acquisition by SV Health Investors, a health care and life sciences focused private investment firm.

EpiVax is a pioneer in pre-clinical drug development, serving as a trusted scientific advisor to life sciences clients. Headquartered in Providence, Rhode Island, EpiVax’s predictive analytical software platform and in vitro laboratory services enable life sciences companies to identify safety and efficacy risks early in drug development, reducing timelines and R&D costs. In partnership with SVHI, EpiVax will continue expanding its capabilities and services, including the planned launch of advanced computational tools, cell-based assay applications, and broader analytical consulting services.

�鶹ֱ��’s health care transactions team was led by partner Joe Derrigo with support from senior counsel Sarah Reinprecht Field and associate Miguel Beltran, partner Jordan Bergmann (Tax), partner Nathan Beaver (Regulatory), and senior counsel Kelsey O’Gorman (Executive Compensation & Benefits).

Man with dark hair and beard wearing a blue blazer and light shirt, smiling in a bright, blurred indoor setting—ideal for a corporate law office or lawyers in Chicago seeking a professional look.

[email protected]

Washington, D.C. 202.295.4145

A woman with straight brown hair, wearing a navy blazer and light shirt, smiles at the camera. The softly blurred background hints at a corporate law office in Chicago, creating a professional atmosphere.

[email protected]

Washington, D.C. 202.672.5496

A man in a blue suit and tie stands in front of a blurred corporate law office background, facing the camera and smiling.

[email protected]

Miami 305.482.8410

Man in a blue suit and polka dot tie smiling, standing in a brightly lit, professional indoor setting—perfectly representing the confidence and expertise of leading Chicago lawyers.

[email protected]

Milwaukee 414.297.4933

Related News

View All Posts

August 24, 2026 Deals and Wins

�鶹ֱ�� Represents TMGOC Ventures in Connection With Preferred Equity Investment for Dual Branded New Orleans Hotel

�鶹ֱ�� & Lardner LLP represented TMGOC Ventures in its origination of a preferred equity investment alongside Access Point Financial, as senior lender, for a total bridge loan and preferred equity investment of $120 million to recapitalize the Kailas Companies’ recently completed conversion of a historic office building into a dual-branded hotel in downtown New Orleans.

August 19, 2026 Deals and Wins

�鶹ֱ�� Represents Canyon Creek Real Estate in Acquisition and Debt Financing of One Eleven Congress

�鶹ֱ�� & Lardner LLP served as legal advisor to Canyon Creek Real Estate in its acquisition and debt financing of One Eleven Congress, a landmark office tower located at 111 Congress Avenue in downtown Austin, Texas.

August 19, 2026 Deals and Wins

�鶹ֱ�� Represents Riot Platforms on $9.1B AI Data Center Lease at Rockdale Campus

�鶹ֱ�� & Lardner LLP represented Riot Platforms, Inc. (NASDAQ: RIOT), a vertically integrated digital infrastructure company specializing in the development of large-scale data centers and bitcoin mining applications, in connection with a landmark 20-year data center lease with a leading frontier AI lab for 191 MW of critical IT capacity at Riot’s Rockdale, Texas campus.

�鶹ֱ��

Popular Searches